MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19

References

• Alhazzani, W., et al., 2020. Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive care medicine, 46 (5), 854–887.
   PubMed Web of Science ®Google Scholar
• Andaluz-Ojeda, D., et al., 2017. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity. Annals of intensive care, 7 (1), 15.
   PubMedGoogle Scholar
• Andrés, C., et al., 2020. MR-proADM to detect specific types of organ failure in infection. European journal of clinical investigation, 50 (6), e13246.
   PubMed Web of Science ®Google Scholar
• Baldirà, J., et al., 2020. Biomarkers and clinical scores to aid the identification of disease severity and intensive care requirement following activation of an in-hospital sepsis code. Annals of intensive care, 10 (1), 7.
   PubMed Web of Science ®Google Scholar
• Caruhel, P., et al., 2009. Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR. Clinical biochemistry, 42 (7–8), 725–728.
   PubMed Web of Science ®Google Scholar
• Charlson, M.E., et al., 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases, 40 (5), 373–383.
   PubMedGoogle Scholar
• Chen, N., et al., 2020a. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395 (10223), 507–513.
   PubMed Web of Science ®Google Scholar
• Chen, Y.T., et al., 2020b. Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis. Critical care, 24 (1), 346.
   PubMed Web of Science ®Google Scholar
• Cheng, Y., et al., 2020. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney international, 97 (5), 829–838.
   PubMed Web of Science ®Google Scholar
• Elke, G., et al., 2018. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis – a secondary analysis of a large randomised controlled trial. Critical Care, 22 (1), 79:
   PubMedGoogle Scholar
• Gabarre, P., et al., 2020. Acute kidney injury in critically ill patients with COVID-19. Intensive care medicine, 46 (7), 1310–1339.
   Web of Science ®Google Scholar
• Gaudry, S., et al., 2016. Initiation strategies for renal-replacement therapy in the intensive care unit. New England journal of medicine, 375 (2), 122–133.
   PubMed Web of Science ®Google Scholar
• Grasselli, G., Pesenti, A., and Cecconi, M., 2020. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA, 323 (16), 1545–1546.
   PubMed Web of Science ®Google Scholar
• Gross, O., et al., 2020. COVID-19-associated nephritis: early warning for disease severity and complications? Lancet, 395 (10236), e87–e88.
   PubMed Web of Science ®Google Scholar
• Guan, W.J., et al., 2020. Clinical characteristics of coronavirus disease 2019 in China. The new England journal of medicine, 382 (18), 1708–1720.
   PubMed Web of Science ®Google Scholar
• Hinson, J.P., Kapas, S., and Smith, D.M., 2000. Adrenomedullin, a multifunctional regulatory peptide. Endocrine reviews, 21 (2), 138–167.
   PubMed Web of Science ®Google Scholar
• Hirsch, J.S., et al., 2020. Acute kidney injury in patients hospitalized with COVID-19. Kidney international, 98 (1), 209–218.
   PubMed Web of Science ®Google Scholar
• Huang, C., et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395 (10223), 497–506.
   PubMed Web of Science ®Google Scholar
• Investigators, R.R.T.S., et al., 2009. Intensity of continuous renal-replacement therapy in critically ill patients. New England journal of medicine, 361 (17), 1627–1638.
   PubMed Web of Science ®Google Scholar
• Joannidis, M., and John, S., 2018. Acute kidney injury and renal replacement therapy in critically ill patients in 2018: recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI. Medizinische klinik - intensivmedizin und notfallmedizin, 113 (5), 356–357.
   PubMed Web of Science ®Google Scholar
• Kluge, S., et al., 2020. German recommendations for critically ill patients with COVID-19. Medizinische klinik, intensivmedizin und notfallmedizin, 115 (Suppl 3), 111–114.
   Web of Science ®Google Scholar
• Le Gall, J.R., Lemeshow, S., and Saulnier, F., 1993. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA, 270 (24), 2957–2963.
   PubMed Web of Science ®Google Scholar
• Lin, G.-L., et al., 2018. Epidemiology and immune pathogenesis of viral sepsis. Frontiers in immunology, 9, 2147–2147.
   PubMed Web of Science ®Google Scholar
• McNicholas, B.A., et al., 2019. Impact of early acute kidney injury on management and outcome in patients with acute respiratory distress syndrome: a secondary analysis of a multicenter observational study. Critical care medicine , 47 (9), 1216–1225.
   PubMed Web of Science ®Google Scholar
• Mearelli, F., et al., 2020. The integration of qSOFA with clinical variables and serum biomarkers improves the prognostic value of qSOFA alone in patients with suspected or confirmed sepsis at ED admission. Journal of clinical medicine, 9 (4), 1205.
   Web of Science ®Google Scholar
• Nierhaus, A., et al., 2018. Predicting the requirement for renal replacement therapy in intensive care patients with sepsis. Critical care, 22 (1), 201.
   PubMedGoogle Scholar
• Önal, U., et al., 2018. Mid-regional pro-adrenomedullin (MR-proADM) as a biomarker for sepsis and septic shock: narrative review. Healthcare, 6 (3), 110.
   Web of Science ®Google Scholar
• Panitchote, A., et al., 2019. Factors associated with acute kidney injury in acute respiratory distress syndrome. Annals of intensive care, 9 (1), 74.
   PubMedGoogle Scholar
• Pons, S., et al., 2020. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Critical care, 24 (1), 353.
   PubMed Web of Science ®Google Scholar
• Puelles, V.G., et al., 2020. Multiorgan and renal tropism of SARS-CoV-2. New England journal of medicine, 383 (6), 590–592.
   PubMed Web of Science ®Google Scholar
• Ranieri, V.M., et al., 2012. Acute respiratory distress syndrome: the Berlin Definition. JAMA, 307 (23), 2526–2533.
   PubMed Web of Science ®Google Scholar
• Richardson, S., et al., 2020. Consortium atNC-R: presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA, 323 (20), 2052–2059.
   PubMed Web of Science ®Google Scholar
• Roedl, K., et al., 2019. The chronic ICU patient: is intensive care worthwhile for patients with very prolonged ICU-stay (≥90 days)? European journal of internal medicine, 69, 71–76.
   PubMed Web of Science ®Google Scholar
• Ronco, C., Reis, T., and Husain-Syed, F., 2020. Management of acute kidney injury in patients with COVID-19. The lancet. Respiratory medicine, 8 (7), 738–742.
   PubMed Web of Science ®Google Scholar
• Ruan, Q., et al., 2020. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine, 46 (5), 846–848.
   PubMed Web of Science ®Google Scholar
• Spoto, S., et al., 2020. How biomarkers can improve pneumonia diagnosis and prognosis: procalcitonin and mid-regional-pro-adrenomedullin. Biomarkers in medicine, 14 (7), 549–562.
   PubMed Web of Science ®Google Scholar
• Teijaro, J.R., et al., 2011. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell, 146 (6), 980–991.
   PubMed Web of Science ®Google Scholar
• Vincent, J.L., et al., 1996. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive care medicine, 22 (7), 707–710.
   PubMed Web of Science ®Google Scholar
• Wang, C., et al., 2020. IL-6 may be a good biomarker for earlier detection of COVID-19 progression. Intensive care medicine, 46 (7), 1472–1475.
   PubMed Web of Science ®Google Scholar
• WHO – World Map – COVID-19. 2020. Accessed January, 15, 2020.
   Google Scholar
• Yang, X., et al., 2020. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Critical care, 24 (1), 356.
   PubMed Web of Science ®Google Scholar
• Zarbock, A., et al., 2016. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA, 315 (20), 2190–2199.
   PubMed Web of Science ®Google Scholar
• Zarbock, A., Gomez, H., and Kellum, J.A., 2014. Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies. Current opinion in critical care, 20 (6), 588–595.
   PubMed Web of Science ®Google Scholar
• Zhou, F., et al., 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan. The lancet , 395 (10229), 1054–1062.
   PubMed Web of Science ®Google Scholar
• Ziesmann, M.T., and Marshall, J.C., 2018. Multiple organ dysfunction: the defining syndrome of sepsis. Surgical infections, 19 (2), 184–190.
   PubMed Web of Science ®Google Scholar